United States Biotechnology & Medical Research

Codiak BioSciences, Inc. (CDAK)

Track

Ticker: CDAK Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Codiak BioSciences, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 30 Mar 2023
Value US$3,103,902.71 | Price 237.15 | Shares 66,814 (+29.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-30 2023-03-30 S Sale
Howze Yalonda

See Remarks

Officer
66,814 +29.1%
237.15
US$3,103,903 		66,814 +29.1% 237.15 US$3,103,903
2023-03-30 2023-03-29 S Sale
1.0
Barna Nicole

See Remarks

Officer
85,387 +22.5%
47.58
US$161,061 		85,387 +22.5% 47.58 US$161,061
2023-03-30 2023-03-29 S Sale
1.0
Barna Nicole

See Remarks

Officer
1,812 +31.7%
32.83
US$1,661,441 		1,812 +31.7% 32.83 US$1,661,441
2023-03-30 2023-03-29 S Sale
Sathyanarayanan Sriram

Chief Scientific Officer

Officer
11,762 -100.0%
0.17
US$1,943 		11,762 -100.0% 0.17 US$1,943
2023-03-30 2023-03-28 S Sale
Bain Linda

Chief Financial Officer

Officer
13,412 -100.0%
0.17
US$2,271 		13,412 -100.0% 0.17 US$2,271
2023-03-30 2023-03-28 S Sale
Konstantinov Konstantin

Chief Technology Officer

Officer
1,932 -100.0%
0.20
US$386 		1,932 -100.0% 0.20 US$386
2023-03-30 2023-03-28 PlS Planned sale
Konstantinov Konstantin

Chief Technology Officer

Officer
7,432 -79.4%
0.20
US$1,487 		7,432 -79.4% 0.20 US$1,487
2023-03-30 2023-03-28 S Sale
WILLIAMS DOUGLAS E

President & CEO

Executive Director
41,667 -84.5%
0.18
US$7,500 		41,667 -84.5% 0.18 US$7,500
2023-02-21 2023-02-17 S Sale
Bain Linda

Chief Financial Officer

Officer
2,570 -16.1%
0.59
US$1,522 		2,570 -16.1% 0.59 US$1,522
2023-02-21 2023-02-17 S Sale
WILLIAMS DOUGLAS E

President & CEO

Executive Director
7,681 -13.5%
0.59
US$4,549 		7,681 -13.5% 0.59 US$4,549
2023-02-21 2023-02-17 S Sale
Howze Yalonda

See Remarks

Officer
1,603 -15.0%
0.59
US$950 		1,603 -15.0% 0.59 US$950
2023-02-21 2023-02-17 S Sale
1.0
Barna Nicole

See Remarks

Officer
1,274 -9.5%
0.59
US$755 		1,274 -9.5% 0.59 US$755
2023-02-21 2023-02-17 S Sale
Konstantinov Konstantin

Chief Technology Officer

Officer
1,391 -15.8%
0.59
US$824 		1,391 -15.8% 0.59 US$824
2023-02-21 2023-02-17 S Sale
Sathyanarayanan Sriram

Chief Scientific Officer

Officer
2,407 -17.0%
0.59
US$1,425 		2,407 -17.0% 0.59 US$1,425
2023-01-23 2023-01-20 S Sale
WILLIAMS DOUGLAS E

See Remarks

Executive Director
5,075 -21.8%
0.58
US$2,918 		5,075 -21.8% 0.58 US$2,918
2023-01-23 2023-01-20 S Sale
1.0
Barna Nicole

See Remarks

Officer
836 -9.3%
0.58
US$481 		836 -9.3% 0.58 US$481
2023-01-23 2023-01-20 S Sale
Sathyanarayanan Sriram

Chief Scientific Officer

Officer
1,082 -38.2%
0.58
US$622 		1,082 -38.2% 0.58 US$622
2023-01-23 2023-01-20 S Sale
Bain Linda

Chief Financial Officer

Officer
1,880 -37.6%
0.58
US$1,081 		1,880 -37.6% 0.58 US$1,081
2023-01-23 2023-01-20 S Sale
Konstantinov Konstantin

Chief Technology Officer

Officer
1,069 -38.2%
0.58
US$615 		1,069 -38.2% 0.58 US$615
2023-01-23 2023-01-20 S Sale
Howze Yalonda

See Remarks

Officer
1,512 -37.8%
0.58
US$870 		1,512 -37.8% 0.58 US$870
2022-09-16 2022-09-15 B Purchase
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
210,743
0.00
US$0 		210,743 0.00 US$0
2022-09-16 2022-09-15 B Purchase
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
722,590
0.00
US$0 		722,590 0.00 US$0
2022-09-15 2022-09-13 B Purchase
ARCH Venture Fund VIII, L.P.
Large shareholder
5,000,000 +129.7%
1.50
US$7,500,000 		5,000,000 +129.7% 1.50 US$7,500,000
2022-09-15 2022-09-13 B Purchase
GILLIS STEVEN
Non-Executive Director
5,000,000
0.00
US$0 		5,000,000 0.00 US$0
2023-02-21 2022-08-17 S Sale
Bain Linda

Chief Financial Officer

Officer
2,364 -22.0%
2.21
US$5,231 		2,364 -22.0% 2.21 US$5,231
2023-02-21 2022-08-17 S Sale
WILLIAMS DOUGLAS E

President & CEO

Executive Director
7,112 -17.3%
2.21
US$15,739 		7,112 -17.3% 2.21 US$15,739
2023-02-21 2022-08-17 S Sale
Howze Yalonda

See Remarks

Officer
1,512 -20.6%
2.21
US$3,347 		1,512 -20.6% 2.21 US$3,347
2023-02-21 2022-08-17 S Sale
1.0
Barna Nicole

See Remarks

Officer
984 -8.7%
2.21
US$2,177 		984 -8.7% 2.21 US$2,177
2023-02-21 2022-08-17 S Sale
Konstantinov Konstantin

Chief Technology Officer

Officer
1,308 -22.1%
2.21
US$2,894 		1,308 -22.1% 2.21 US$2,894
2023-02-21 2022-08-17 S Sale
Sathyanarayanan Sriram

Chief Scientific Officer

Officer
2,283 -25.1%
2.21
US$5,051 		2,283 -25.1% 2.21 US$5,051
2022-02-07 2022-01-20 B Purchase
1.0
Barna Nicole

See Remarks

Officer
6,781 +inf%
7.37
US$49,978 		6,781 +inf% 7.37 US$49,978
2021-09-28 2021-08-09 PlS Planned sale
Sathyanarayanan Sriram

Chief Scientific Officer

Officer
549 -100.0%
21.79
US$11,962 		549 -100.0% 21.79 US$11,962
2021-09-28 2021-08-09 PlS Planned sale
Sathyanarayanan Sriram

Chief Scientific Officer

Officer
751 -57.8%
21.31
US$16,003 		751 -57.8% 21.31 US$16,003
2021-09-28 2021-08-06 PlS Planned sale
Sathyanarayanan Sriram

Chief Scientific Officer

Officer
1,300 -100.0%
20.16
US$26,206 		1,300 -100.0% 20.16 US$26,206
2021-09-28 2021-06-08 PlS Planned sale
Sorensen Benny

See Remarks

Officer
1,640 -100.0%
26.06
US$42,740 		1,640 -100.0% 26.06 US$42,740
2021-09-28 2021-06-08 PlS Planned sale
Sorensen Benny

See Remarks

Officer
6,893 -80.8%
25.57
US$176,276 		6,893 -80.8% 25.57 US$176,276
2021-09-28 2021-06-08 PlS Planned sale
Konstantinov Konstantin

Chief Technology Officer

Officer
1,004 -100.0%
26.04
US$26,146 		1,004 -100.0% 26.04 US$26,146
2021-09-28 2021-06-08 PlS Planned sale
Konstantinov Konstantin

Chief Technology Officer

Officer
6,272 -86.2%
25.53
US$160,130 		6,272 -86.2% 25.53 US$160,130
2021-02-17 2021-02-17 B Purchase
3.3
Morrison Briggs
Non-Executive Director
4,761 +inf%
21.00
US$99,981 		4,761 +inf% 21.00 US$99,981
2020-10-23 2020-10-16 B Purchase
Alaska Permanent Fund Corp
Large shareholder
235,000 +5.5%
15.00
US$3,525,000 		235,000 +5.5% 15.00 US$3,525,000
2020-10-20 2020-10-16 B Purchase
GILLIS STEVEN
Non-Executive Director
235,000 +10.4%
15.00
US$3,525,000 		235,000 +10.4% 15.00 US$3,525,000
2020-10-20 2020-10-16 B Purchase
ARCH Venture Fund VIII, L.P.
Large shareholder
235,000 +10.4%
15.00
US$3,525,000 		235,000 +10.4% 15.00 US$3,525,000
2020-10-20 2020-10-16 B Purchase
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
165,000 +16.9%
15.00
US$2,475,000 		165,000 +16.9% 15.00 US$2,475,000
2021-04-30 2020-10-13 B Purchase
2.4
MELAS KYRIAZI THEO
Non-Executive Director
6,600 +inf%
15.00
US$99,000 		6,600 +inf% 15.00 US$99,000
Explore more

More insider trading research around Codiak BioSciences, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America